A phase II feasibility study assessing the delivery of intravesical botulinum toxin A using low energy shock waves in treatment of overactive bladder
Latest Information Update: 07 Oct 2019
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
Most Recent Events
- 07 Oct 2019 New trial record